The history of diabetes research in Canada is, in every sense, a history of innovation. From the world-changing discovery of insulin by Sir Frederick Banting and Dr. Charles Best, to the more recent breakthrough in islet transplantation known as the Edmonton Protocol, Canadian researchers have made an immeasurable impact upon the lives of those with diabetes. JDRF CCTN is designed to ensure that Canada maintains its tradition of innovation in diabetes research.
Our mission is to accelerate the development of new treatments and technologies for the treatment of type 1 diabetes (T1D) and its complications in Canada.
The goals of JDRF CCTN are:
- To create an improved, nationwide infrastructure for diabetes clinical trials in Canada, in order to enable greater clinical trial capacity;
- To conduct advanced clinical trials of leading-edge treatments and technologies for T1D;
- To provide Canadians with T1D access to the latest diabetes breakthroughs via participating in clinical trials; and
- To create new partnerships between academic researchers, non-profit organizations, industry, and government to accelerate preventions, better treatments, and a cure for T1D and its complications.